Catherine A. Shu, MD
@catherineshumd
Thoracic medical oncologist @ColumbiaMed. Lucky mother of two lovely children. Board game, food, and grammar enthusiast. Views my own.
ID: 1530005201758846993
27-05-2022 01:57:29
83 Tweet
334 Followers
74 Following
While I enjoy being in academia (although I would hardly consider myself a real scientist), I also greatly appreciated this article by Adam Ruben. (Also, were you my DM at Princeton Band?!)
Bravi! Absolutely right, & we're stressing NGS every day throughout our multi-stakeholder organization, exon20group.org ...so your excellent JTO & JTO CRR commentary building upon Santiago Viteri + Joshua Bauml, MD + Anna Minchom + LudaBazhenovaMD article, febs.onlinelibrary.wiley.com/doi/full/10.10… is
When discussing adjuvant osimertinib- can’t downplay chronic toxicity of long term targeted therapy. Dr. Ben Solomon credits Jill Feldman for highlighting this critical aspect of cancer care - with rousing applause from the #ASCO23 audience.
Yes!! Superb Jonathan Riess, MD MS analysis of Keynote-789, zorifertinib, and sunvozertinib. Promising ORR and CNS activity for #sunvozertinib in #EGFR #Exon20 and it will be important to see sunvo continue to be studied in the treatment-naive setting. #ASCO23
To all of the Melanoma and/or Rare Tumor Experts in the Twitterverse - We are recruiting Herbert Irving Comprehensive Cancer Center in NYC. If you ❤️NY and are interested in joining our exceptional team DM me. cancer.columbia.edu
I am looking forward to presenting RAMOSE trial in EGFR mut lung cancer pts at #ESMO23 LBA71 MD Anderson Cancer Center EGFR Resisters @exon20
Thanks Great Debates for having me! Turns out there were a lot of secret Swifties in the audience!